A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease

BACKGROUND: Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true slowing of the neurodegenerative process. A systematic review was undertaken to determine what bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: McGhee, David J. M., Ritchie, Craig W., Thompson, Paul A., Wright, David E., Zajicek, John P., Counsell, Carl E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928315/
https://www.ncbi.nlm.nih.gov/pubmed/24558437
http://dx.doi.org/10.1371/journal.pone.0088854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928315/
https://www.ncbi.nlm.nih.gov/pubmed/24558437
http://dx.doi.org/10.1371/journal.pone.0088854

Ejemplares similares